Salt (sodium chloride) is an essential nutrient required to maintain physiological functions.
However, for most people, daily salt intake far exceeds their physiological need and is …

Although immunomodulation may be advantageous as a causal therapy in hypertension,
targeting immune networks rather than single interleukins appears of major importance …

Background Atrial fibrillation (AF) is a common comorbidity in heart failure with preserved
ejection fraction (HFpEF) patients. To date, treatments for HFpEF-related AF have been …

Heart failure with preserved ejection fraction (HFpEF) is one of the most complex and most
prevalent cardiometabolic diseases in aging population. Age, obesity, diabetes, and …

Heart failure with preserved ejection fraction (HFpEF) is a major public health concern. Its
outcome is poor and, as of today, barely any treatments have been able to decrease its …

Cardiovascular diseases (CVDs) represent a major concern for human health worldwide.
Emergencies in this field include wide repertories of studies dealing primarily with CVD …

Heart failure, a leading cause of hospitalizations and deaths, is a major clinical problem. In
recent years, the increasing incidence of heart failure with preserved ejection fraction …

Renal denervation (RDN) protects against hypertension, hypertrophy, and heart failure (HF);
however, it is not clear whether RDN preserves ejection fraction (EF) during heart failure …

Heart failure, a pervasive global health burden, necessitates innovative therapeutic
strategies. Extracellular vesicles (EVs) have emerged as promising contenders for cardiac …

The pathogenesis of heart failure with preserved ejection fraction (HFpEF) remains unclear,
and effective treatments are limited. HFpEF is more prevalent in females, indicating potential …